跳至主要内容
临床试验/NCT04714242
NCT04714242已完成不适用

Choroid and Choriocapillary Changes in Polypoidal Choroidal Vasculopathy After Intravitreal Anti-VEGF Therapy

Federico II University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年1月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Study of vascular features of choroid in polypoidal choroidal vasculopathy after intravitreal injections of Ranibizumab

研究概览

简要总结

To investigate the structural and vascular features of choroid in patients affected by PCV after Ranibizumab intravitreal injection.

详细描述

Polypoidal choroidal vasculopathy represents a distinct form of choroidal neovascularization.

The study investigated the changes in choroidal vascular network after anti-VEGF therapy using optical coherence tomography angiography, a novel and non invasive diagnostic technique that allows to better understand the pathophysiologic mechanism of this neovascularization.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
60 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age older than 60 years
  • diagnosis of polypoidal choroidal vasculopathy
  • absence of previous ocular surgery, congenital eye disease, high myopia (>6 dioptres), actual or previous diagnosis of glaucoma, optic disc anomaly, macular or vitreoretinal diseases.
  • absence of significant lens opacities, low-quality OCT-A images.

排除标准

  • age older than 80 years
  • absence of diagnosis of polypoidal choroidal vasculopathy
  • presence of previous ocular surgery, congenital eye disease, high myopia (>6 dioptres), actual or previous diagnosis of glaucoma, optic disc anomaly, macular or vitreoretinal diseases.
  • presence of significant lens opacities, low-quality OCT-A images.

研究组 & 干预措施

Patients underwent anti-VEGF therapy

intravitreal Anti-VEGF therapy: Three monthly intravitreal injections

干预措施: Ranibizumab Injection (Drug)

结局指标

主要结局

Study of vascular features of choroid in polypoidal choroidal vasculopathy after intravitreal injections of Ranibizumab

时间窗: 12 Months

The effectiveness of Ranibizumab injections for treating PCV using optical optical coherence tomography angiography. The parameters analyzed by optical coherence tomography angiography were: choriocapillaris vessel density.

次要结局

  • Study of structural features of choroid in polypoidal choroidal vasculopathy after intravitreal(12 Months)

研究者

发起方
Federico II University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gilda Cennamo

Principal Investigator

Federico II University

研究点 (1)

Loading locations...

相似试验